Julie Lajoie

Dr. Julie Lajoie

Departments of Medical Microbiology and Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Drug Metabolism and Disposition
Verified
Journal Article
Closed access
PDF file
JRJean-Nicholas Roy
Jean-Nicholas Roy
JLJulie Lajoie
Julie Lajoie
LZLynn S. Zijenah
Lynn S. Zijenah
ABAzemi Barama
Azemi Barama
CPCharles Poirier
Charles Poirier
MRMichel Roger
Michel Roger
Cyp3A5 activity varies within any given ethnic population, suggesting that genetic variation within the Cyp3A5 gene may be the most important contributor to interindividual and interracial differences in Cyp3A-dependent drug clearance and response. The full extent of Cyp3A5 polymorphism in a white and an indigenous African population was analyzed using DNA direct sequencing procedures. The presence of 10 and 12 single nucleotide polymorphisms was detected in the white and African samples, respectively. Thirteen novel mutations occurring at low frequencies were identified in these populations. Significant differences were observed in the distribution of Cyp3A5*3, Cyp3A5*6, and Cyp3A5*7 alleles among white and African populations. The frequency of Cyp3A5*3 allele in white Canadians (∼93%) is higher than in Zimbabweans (77.6%) (p < 0.001). In contrast, Cyp3A5*6 and Cyp3A5*7 alleles are relatively frequent in African subjects (10–22%) but absent in white subjects (p < 0.001). These differences may reflect evolutionary pressures generated by environmental factors in geographically distinct regions. However, the genetic polymorphism of Cyp3A5 alone does not explain the interindividual differences in Cyp3A-mediated metabolism.

8 February 2012 in Mucosal Immunology
Verified
Journal Article
Closed access
PDF file
JLJulie Lajoie
Julie Lajoie
JJJennifer Juno
Jennifer Juno
ABA Burgener
A Burgener
SRS Rahman
S Rahman
KMK Mogk
K Mogk
KFKeith Fowke
Keith Fowke

5 October 2011 in Journal of Proteome Research
Verified
Journal Article
Closed access
ABA. Burgener
A. Burgener
SRS. Rahman
S. Rahman
RAR. Ahmad
R. Ahmad
JLJulie Lajoie
Julie Lajoie
SRS. Ramdahin
S. Ramdahin
TBT. B. Ball
T. B. Ball

15 January 2006 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JLJulie Lajoie
Julie Lajoie
JHJohn Hargrove
John Hargrove
LZLynn S. Zijenah
Lynn S. Zijenah
JHJean H. Humphrey
Jean H. Humphrey
BWBrian J. Ward
Brian J. Ward
MRMichel Roger
Michel Roger
Human leukocyte antigen (HLA)–E and HLA-G molecules act as powerful modulators of the innate immune response. The present study shows that the HLA-EG

12 January 2014 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JLJulie Lajoie
Julie Lajoie
MKMakubo Kimani
Makubo Kimani
FPFrancis A. Plummer
Francis A. Plummer
FNFrancis Nyamiobo
Francis Nyamiobo
RKRupert Kaul
Rupert Kaul
KFKeith Fowke
Keith Fowke
Background. Unprotected intercourse and seminal discharge are powerful activators of the mucosal immune system and are important risk factors for transmission of human immunodeficiency virus (HIV). This study was designed to determine if female sex work is associated with changes in the mucosal immunity. Methods. Cervicovaginal lavage and plasma from 122 HIV-uninfected female sex workers (FSW) and 44 HIV-uninfected low-risk non-FSW from the same socioeconomic district of Nairobi were analyzed for evidence of immune activation (IA). The cervico-mononuclear cells (CMC) were analyzed for cellular activation by flow cytometry. Results. Lower IA was observed in FSW compared to the low-risk women as demonstrated by the lower level of MIP-3α (P < .001), ITAC (P < .001), MIG (p.0001), IL-1α (P < .001), IL-1β (P < .001), IL-1Rα (P = .0002), IL-6 (P < .001), IL-8 (P < .001), IL-10 (P = .01), IP-10 (P = .0001), MDC (P < .001), MIP-1α, (P < .001), MIP-1β (P = .005), MCP-1 (P = .03), and TNF-α (P = .006). Significant differences were noted as early as 1 year following initiation of sex work and increased with duration of sex work. Conclusion. This study showed that sex work is associated with important changes in the mucosal immune system. By analyzing chemokine/cytokine levels and CMC activation, we observed a lower mucosal IA in HIV-uninfected FSW compared to low-risk women.

1 February 2004 in AIDS
Verified
Journal Article
Closed access
CMClaudine Matte
Claudine Matte
JLJulie Lajoie
Julie Lajoie
JLJulie Lacaille
Julie Lacaille
LZLynn S Zijenah
Lynn S Zijenah
BWBrian J Ward
Brian J Ward
MRMichel Roger
Michel Roger
Heterosexual transmission of HIV-1 is the major route of infection worldwide. HLA-G molecules are involved in the inhibition of cell-mediated immune responses and could permit or even promote the propagation of infection in the female reproductive tract. To examine whether HLA-G genetic variants are associated with the risk of heterosexual HIV-1 infection. HLA-G polymorphism in DNA samples from 431 (228 HIV-positive and 203 HIV-negative) Zimbabwean women was determined by amplified-restriction fragment length polymorphism and DNA sequencing analyses. Six HLA-G alleles were identified in the study population. HLA-G*0105N, which does not encode functional HLA-G1 proteins, was significantly associated with protection from HIV-1 infection [odds ratio (OR), 0.51; 95% confidence interval (CI), 0.31–0.85; P = 0.0083). The HLA-G*010108 allele was associated with a 2.5-fold increased risk of HIV-1 infection (OR, 2.47; 95% CI, 1.32–4.64; P = 0.0038). In addition, two HLA-G*010108-containing genotypes were associated with elevated risk of HIV-1 infection: HLA-G*010108/010401 (OR, 23.6; 95% CI, 1.39–401.7; P = 0.0009) and G*010101/010108 (OR, 5.6; 95% CI, 1.24–25.3; P = 0.012). This study demonstrates that functionally active HLA-G polymorphisms are associated with altered risk of HIV-1 infection in African women. This provides evidence to support the hypothesis that modulation of HLA-G expression by HIV-1 can contribute to the risk of infection. Targeted interventions to reduce or block HLA-G expression in genital tissues could lead to novel strategies for the prevention of heterosexual HIV-1 transmission.